| Size: | Price | Quantity | |
|---|---|---|---|
| 5 mg | $75.00 | ||
| 25 mg | $270.00 |
TN-2-30 (943820-93-7) is part of the chemical cocktail SCF/2i-IG that enables the long-term expansion of mouse and human granulocyte-monocyte progenitor (GMP) cells.1 This cocktail allows extensive clonal expansion while retaining canonical immunophenotype, GMP-like chromatin and transcriptional profiles, and intact myeloid differentiation outputs. TN-2-30 was found to contribute to these effects via myeloperoxidase inhibition. TN-2-30 was originally found to be a Wnt/ß-catenin agonist2, but this pathway was not involved in the enhancement of clonal expansion. An interesting new tool for exploring the use of expandable GMPs for engineered tumor immunotherapy.
References/Citations:
C13H12N4O3
>98% HPLC
NMR: (Conforms)
Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications. Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee
TN-2-30 (943820-93-7) is part of the chemical cocktail SCF/2i-IG that enables the long-term expansion of mouse and human granulocyte-monocyte progenitor (GMP) cells.1 This cocktail allows extensive clonal expansion while retaining canonical immunophenotype, GMP-like chromatin and transcriptional profiles, and intact myeloid differentiation outputs. TN-2-30 was found to contribute to these effects via myeloperoxidase inhibition. TN-2-30 was originally found to be a Wnt/ß-catenin agonist2, but this pathway was not involved in the enhancement of clonal expansion. An interesting new tool for exploring the use of expandable GMPs for engineered tumor immunotherapy.
References/Citations:
Calculate the molar concentration, mass or volume in a solution.
Concentration × Volume × Molecular Weight = Mass
BOGO